Coloplast A/S-Sponsored ADRCLPBY

13F holders, Q2 2026 (June 30)
4holders −3
0new positions
3sold out
$5.70avg. 13F price*

At the end of Q2 2026, 4 institutions reported holding Coloplast A/S-Sponsored ADR (CLPBY) in their 13F filings, down 3 from Q1 2026. 0 opened new positions and 3 sold out. The largest holders were Rhumbline Advisers ($840K), GAMMA Investing LLC ($114K) and PNC Financial Services Group, Inc. ($26K).

Company
Coloplast A/S-Sponsored ADR
CUSIP
19624Y200
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246810 Q1 2024: 8Q1 2024Q2 2024: 7Q2 2024Q3 2024: 8Q3 2024Q4 2024: 8Q4 2024Q1 2025: 9Q1 2025Q2 2025: 9Q2 2025Q3 2025: 7Q3 2025Q4 2025: 8Q4 2025Q1 2026: 7Q1 2026Q2 2026: 4Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions0$0
Exits3$575K

All 13F filers, Q1 2026 → Q2 2026: 40,675 shares bought and 94,185 shares sold, net −53,510 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

Rhumbline Advisers 0.00% Add +29.1% 147,301 $840K
GAMMA Investing LLC 0.00% Add +60.2% 19,983 $114K
PNC Financial Services Group, Inc. 0.00% Reduce -58.6% 4,567 $26K
Salomon & Ludwin, LLC 0.00% Reduce -92.5% 229 $1K

"% of holder's portfolio" is CLPBY's weight in each manager's 13F, not the share of Coloplast A/S-Sponsored ADR the manager owns.